Skip to main content
. 2021 Jan 7;11(1):74. doi: 10.3390/biom11010074
3CLpro or Mpro 3-Chymotrypsin-like protease or Main protease
ACE2 Angiotensin-converting enzyme 2
CC50 Cytotoxic concentration of the compound that reduced cell viability to 50%
CoVs Coronaviruses
DPP4 Dipeptidyl-peptidase 4
EC50 Effective concentration of compound needed to inhibit 50% of cytopathic effect
fRhK-4 Fetal rhesus kidney-4
GL Glycyrrhizin
HBV Hepatitis B virus
HCoV Human coronavirus
HCV Hepatitis C virus
IBV Infectious bronchitis virus
MD Molecular dynamics
MERS-CoV Middle East Respiratory Syndrome-CoV
MHV Mouse hepatitis virus
ORF1a Open reading frame 1a
ORF1b Open reading frame 1b
PLpro Papain-like protease 2
PP1a Polyprotein ia
PP1b Polyprotein 1b
RdRp RNA-dependent RNA polymerase
SARS-CoV Severe Acute Respiratory Syndrome-CoV
SARS-CoV-2 Severe Acute Respiratory Syndrome-CoV-2
SI Selectivity index
TGEV Transmissible gastroenteritis virus